财务福利和记忆功能的变化以及中年和老年人的下降
Katrina L Kezios1,2, Jordan Vo3, Zihan Chen1
1Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States.
American journal of epidemiology
|March 16, 2026
概括
财务福祉的变化会影响老年人的认知衰老. 财务福祉的下降与记忆功能低下和认知能力下降的加快有关,特别是在65岁及以上的人群中.
科学领域:
- 老年学是一门学科.
- 认知神经科学 认知神经科学
- 社会经济学 社会经济学
背景情况:
- 财务不安全在老年人中普遍存在.
- 之前的研究将社会经济地位,财务压力和冲击与认知能力下降联系起来.
- 有限的研究探讨了动态的财务福祉如何影响认知衰老.
研究的目的:
- 调查50岁及以上成年人财务福祉变化与记忆结果之间的关联.
- 检查平均财务福利和显著改善或恶化如何随着时间的推移影响认知衰老.
主要方法:
- 在健康和退休研究 (2010-2020) 中利用了50岁以上的7676名成年人的数据.
- 开发并验证了8项指数,用于较差的财务福祉.
- 采用线性混合效应模型来评估财务福祉变化与记忆z分数 (2016-2020) 之间的关联.
主要成果:
- 平均财务福祉每1个点的恶化与较差的记忆功能 (β = -0.009 SD) 和加速下降 (β = -0.007 SD/年) 相相关.
- 最显著的关联是观察到参与者经历了实质性的财务福祉恶化和65岁以上的人在基线.
- 在对逆因果关系和磨损的敏感性分析后,研究结果仍然强大.
结论:
- 在中年和晚年生活中,财务福祉的下降可能会导致加速的认知衰老.
- 财务状况的动态变化是认知健康轨迹的关键因素.
- 旨在改善财务福祉的干预措施可以支持老年人群的认知健康.
相关概念视频
01:30Cognitive Development During Adulthood
1.1K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.1K
01:26Aging
964
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
964
01:19The Effect of Aging on Tissues
4.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.1K
01:23Role of Neurotransmitters in Memory
2.8K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.8K
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
309
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
309